Zhang Peng, Zhang Li, Liu Hui, Zhao Lei, Li Yong, Shen Jing-Xian, Liu Qing, Liu Meng-Zhong, Xi Mian
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Cancer Res Treat. 2017 Jul;49(3):695-705. doi: 10.4143/crt.2016.317. Epub 2016 Oct 11.
Previous studies reported an association between an increased risk of tongue cancer and radiation treatment for nasopharyngeal carcinoma (NPC). This study compared the clinicopathologic characteristics and outcomes of tongue squamous cell carcinoma (TSCC) in patients with and without a history of radiotherapy for NPC.
From 1965 to 2009, a total of 73 patients were diagnosed with TSCC with a history of radiotherapy for NPC. The patients were matched in a 1:3 ratio with patients with sporadic TSCC according to age, sex, and year of the TSCC diagnosis. The primary endpoint was the overall survival.
The median interval from NPC to TSCC was 82 months. The NPC survivors were more likely to be diagnosed with a more advanced T classification, less likely to have lymph node involvement, and more likely to have the tumor located in the dorsum of the tongue than sporadic TSCC. Regarding the histologic characteristics, the NPC survivors were more likely to have a weak lymphocytic host response, low tumor budding, and low risk of a worse pattern of invasion. The sporadic TSCC patients had a better overall survival (hazard ratio, 0.690; p=0.033) than the NPC survivors. In competing risks analysis, the cumulative incidence functions for the competing event (documented non-tongue cancer death) were significantly higher in the NPC survivors (Gray's test, p=0.001).
TSCC patients with a history of radiotherapy for NPC appear to have particular clinicopathologic features, a poorer survival, and are more likely to die from non-tongue cancer causes than those with sporadic TSCC.
既往研究报道鼻咽癌(NPC)放疗与舌癌风险增加之间存在关联。本研究比较了有和无NPC放疗史患者的舌鳞状细胞癌(TSCC)的临床病理特征及预后。
1965年至2009年,共有73例诊断为TSCC且有NPC放疗史的患者。根据年龄、性别和TSCC诊断年份,将这些患者与散发性TSCC患者按1:3的比例进行匹配。主要终点为总生存期。
从NPC到TSCC的中位间隔时间为82个月。与散发性TSCC相比,NPC幸存者更易被诊断为更高级别的T分类,淋巴结受累的可能性更小,且肿瘤更易位于舌背。关于组织学特征,NPC幸存者更易出现淋巴细胞宿主反应较弱、肿瘤芽生较少以及侵袭模式较差风险较低的情况。散发性TSCC患者的总生存期优于NPC幸存者(风险比,0.690;p = 0.033)。在竞争风险分析中,NPC幸存者中竞争事件(记录的非舌癌死亡)的累积发生率函数显著更高(Gray检验,p = 0.001)。
有NPC放疗史的TSCC患者似乎具有特定的临床病理特征,生存期较差,且比散发性TSCC患者更易死于非舌癌原因。